Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
about
Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.The role of surgical debridement in different clinical manifestations of invasive aspergillosis.Non-cultural methods for the diagnosis of invasive fungal disease.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection.Serum and urine galactomannan testing for screening in patients with hematological malignancies.Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.Treatment of AspergillosisInvasive Aspergillosis in Children: Update on Current Guidelines
P2860
Q33703531-83A97671-822A-4205-A80C-DD940989C945Q36396166-62E1DA78-33B1-4EAE-8DD4-1F83BDAD4998Q38245929-4AD4C2FE-502B-4F31-B245-9E32065293C4Q38266817-E85025A1-3CDA-46FE-804D-66CB63486412Q38508539-521ED8D0-84C7-4E4E-9DCC-28C59CEA8F8AQ38979163-2789D3D9-EFEC-4897-9696-E1F4D9211C41Q38979166-F700AC31-1106-4A3E-953F-D3BA27BC2B9FQ38983367-5088BC5E-E1C1-41B6-9995-3048098E181FQ39062930-D2BEB787-594E-48D3-9335-D4B47EEC5275Q39367509-AA8F0984-DA89-4611-B132-69716580204DQ39391519-82871F19-0215-4CE3-8174-01C91F6DF6F1Q58765898-47C4503A-66B8-4448-B3B9-5D4385DDC85BQ58775551-66B28204-541F-48CA-AFFF-60DF389C3559
P2860
Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Sensitivity of galactomannan e ...... hylaxis and empirical therapy.
@en
Sensitivity of galactomannan e ...... hylaxis and empirical therapy.
@nl
type
label
Sensitivity of galactomannan e ...... hylaxis and empirical therapy.
@en
Sensitivity of galactomannan e ...... hylaxis and empirical therapy.
@nl
prefLabel
Sensitivity of galactomannan e ...... hylaxis and empirical therapy.
@en
Sensitivity of galactomannan e ...... hylaxis and empirical therapy.
@nl
P2093
P2860
P356
P1433
P1476
Sensitivity of galactomannan e ...... hylaxis and empirical therapy.
@en
P2093
Albert Wölfler
Christoph Koidl
Jasmin Wagner
Katharina Seeber
Robert Krause
Volker Strenger
Walter Buzina
Wiebke Duettmann
P2860
P304
P356
10.1111/MYC.12060
P577
2013-02-24T00:00:00Z